Zevra Therapeutics, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Zevra Therapeutics, Inc. (ZVRA) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 2.69 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-05
- Zevra Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 2.69M shares, a 1.77% decline year-over-year.
- Zevra Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 3.01M shares, a 77.26% decline year-over-year.
- Zevra Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 11.49M shares, a 20.63% decline year-over-year.
- Zevra Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 2.74M shares, a 82.13% decline year-over-year.
- Zevra Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 1.57M shares, a 76.31% decline from fiscal 2024.
- Zevra Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 6.63M shares, a 9.56% decline from fiscal 2023.
- Zevra Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 7.33M shares, a 9.30% increase from fiscal 2022.
- Zevra Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 6.71M shares, a 22.09% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2.69M shares 10-Q · filed 2026-08-05 | 2.69M shares 10-Q · filed 2026-08-05 | ||||||
| 2026-03-31 | 3.01M shares 10-Q · filed 2026-05-06 | |||||||
| 2025-12-31 | 1.57M shares 10-K · filed 2026-03-09 | |||||||
| 2025-09-30 | 11.49M shares 10-Q · filed 2025-11-05 | 1.77M shares 10-Q · filed 2025-11-05 | ||||||
| 2025-06-30 | 2.74M shares 10-Q · filed 2026-08-05 | 2.74M shares 10-Q · filed 2026-08-05 | ||||||
| 2025-03-31 | 13.22M shares 10-Q · filed 2026-05-06 | |||||||
| 2024-12-31 | 6.63M shares 10-K · filed 2026-03-09 | |||||||
| 2024-09-30 | 14.47M shares 10-Q · filed 2025-11-05 | 14.47M shares 10-Q · filed 2025-11-05 | ||||||
| 2024-06-30 | 15.33M shares 10-Q · filed 2025-08-12 | 15.33M shares 10-Q · filed 2025-08-12 | ||||||
| 2024-03-31 | 9.97M shares 10-Q · filed 2025-05-13 | |||||||
| 2023-12-31 | 7.33M shares 10-K · filed 2025-03-12 | |||||||
| 2023-09-30 | 11.51M shares 10-Q · filed 2024-11-13 | 11.51M shares 10-Q · filed 2024-11-13 | ||||||
| 2023-06-30 | 11.28M shares 10-Q · filed 2024-08-14 | 11.28M shares 10-Q · filed 2024-08-14 | ||||||
| 2023-03-31 | 10.28M shares 10-Q · filed 2024-05-09 | |||||||
| 2022-12-31 | 6.71M shares 10-K · filed 2024-04-01 | |||||||
| 2022-09-30 | 6.72M shares 10-Q · filed 2023-11-07 | 6.72M shares 10-Q · filed 2023-11-07 | ||||||
| 2022-06-30 | 6.78M shares 10-Q · filed 2023-08-14 | 6.78M shares 10-Q · filed 2023-08-14 | ||||||
| 2022-03-31 | 6.44M shares 10-Q · filed 2023-05-15 | |||||||
| 2021-12-31 | 5.50M shares 10-K · filed 2023-03-07 | |||||||
| 2021-09-30 | 5.39M shares 10-Q · filed 2022-11-10 | 5.27M shares 10-Q · filed 2021-11-10 | 5.39M shares 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | 5.00M shares 10-Q · filed 2022-08-12 | 5.00M shares 10-Q · filed 2022-08-12 | ||||||
| 2021-03-31 | 9.90M shares 10-Q · filed 2022-05-12 | |||||||
| 2020-12-31 | 1.25M shares 10-K · filed 2022-03-31 | |||||||
| 2020-09-30 | 1.23M shares 10-Q · filed 2021-11-10 | 19.76M shares 10-Q · filed 2020-10-30 | 1.23M shares 10-Q · filed 2021-11-10 | 19.76M shares 10-Q · filed 2020-10-30 | ||||
| 2020-06-30 | 1.55M shares 10-Q · filed 2021-08-13 | 24.76M shares 10-Q · filed 2020-08-12 | 1.55M shares 10-Q · filed 2021-08-13 | 24.78M shares 10-Q · filed 2020-08-12 | ||||
| 2020-03-31 | 1.90M shares 10-Q · filed 2021-05-14 | 30.45M shares 10-Q · filed 2020-05-13 | ||||||
| 2019-12-31 | 2.41M shares 10-K · filed 2021-03-12 | 38.63M shares 10-K · filed 2020-02-28 | ||||||
| 2019-09-30 | 37.48M shares 10-Q · filed 2020-10-30 | 41.35M shares 10-Q · filed 2020-10-30 | ||||||
| 2019-06-30 | 14.25M shares 10-Q · filed 2020-08-12 | 14.25M shares 10-Q · filed 2020-08-12 | ||||||
| 2019-03-31 | 14.41M shares 10-Q · filed 2020-05-13 | |||||||
| 2018-12-31 | 12.99M shares 10-K · filed 2020-02-28 | |||||||
| 2018-09-30 | 11.94M shares 10-Q · filed 2019-11-14 | 11.94M shares 10-Q · filed 2019-11-14 | ||||||
| 2018-06-30 | 8.83M shares 10-Q · filed 2019-08-13 | 11.90M shares 10-Q · filed 2019-08-13 | ||||||
| 2018-03-31 | 12.45M shares 10-Q · filed 2019-05-14 | |||||||
| 2017-12-31 | 11.67M shares 10-K · filed 2019-03-01 | |||||||
| 2017-09-30 | 11.69M shares 10-Q · filed 2018-11-09 | 11.69M shares 10-Q · filed 2018-11-09 | ||||||
| 2017-06-30 | 11.69M shares 10-Q · filed 2018-08-10 | 11.69M shares 10-Q · filed 2018-08-10 | ||||||
| 2017-03-31 | 11.70M shares 10-Q · filed 2018-05-11 | |||||||
| 2016-12-31 | 10.87M shares 10-K · filed 2018-03-30 | |||||||
| 2016-09-30 | 11.10M shares 10-Q · filed 2016-11-10 | 11.10M shares 10-Q · filed 2017-11-09 | 5.97M shares 10-Q · filed 2016-11-10 | |||||
| 2016-06-30 | 9.53M shares 10-Q · filed 2016-08-11 | 9.53M shares 10-Q · filed 2017-08-10 | 5.49M shares 10-Q · filed 2016-08-11 | |||||
| 2016-03-31 | 11.35M shares 10-Q · filed 2017-05-22 | |||||||
| 2015-12-31 | 5.71M shares 10-K · filed 2018-03-30 | |||||||
| 2015-09-30 | 5.97M shares 10-Q · filed 2015-11-13 | 12.07M shares 10-Q · filed 2015-11-13 | ||||||
| 2015-06-30 | 5.49M shares 10-Q · filed 2015-08-14 | |||||||
| 2015-03-31 | 11.05M shares 10-Q · filed 2016-05-13 | |||||||
| 2014-12-31 | 10.43M shares 10-K · filed 2017-03-10 | |||||||
| 2014-06-30 | 11.00M shares 10-Q · filed 2015-08-14 | |||||||
| 2014-03-31 | 6.33M shares 10-Q · filed 2015-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |